Maryland Oncology Hematology, PA- Columbia

Columbia, Maryland 21044

0 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia, Breast Cancer, Chondrosarcoma, Chronic Lymphocytic Leukemia, Colorectal Cancer, HER2/Neu Positive, Non Hodgkin Lymphoma, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Progesterone Receptor Positive, Recurrent Breast Carcinoma

Studies at this site

• Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer — Completed
• A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis — Running, not enrolling
• Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer — Completed
• Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers — Stopped early
• Breast Cancer Index (BCI) Registry — Running, not enrolling